![]() |
인쇄하기
취소
|
On June 24, Korean Pharmaceutical Manufacturers Association held 'Second Seminar of the National Health Insurance Act revision'.
Each pharmaceutical company is conducting self-purification activities such as declaration of CP, but regardless of that, how to take ambiguous regulations emerged as a major concern.
Ministry of Health and Welfare announced on the seminar that they will compensate ...